Mandate

Vinge represents Sidec Technologies in the issue of new shares

May 09, 2007

Vinge is representing Sidec Technologies, in conjunction with the investments by Industrifonden, Investor and Earlybird of Germany in the company. A capital infusion of SEK 68.5 million means that Sidec can implement its planned efforts on the European and American markets. The company, which was established in 2000, is a spin-off from research at the Karolinska Institute, and is engaged in technology developed for studies of protein.
 
Partner Johan Winnerbald and associate Anna Berntsson represent Sidec Technologies AB.

Related

Vinge advises in connection with data center provider EcoDataCenter’s tap issue of SEK 500 million bonds

Vinge has advised in connection with EcoDC Holding AB (publ)'s tap issue of SEK 500 million senior unsecured bonds under the existing framework of up to SEK 2 billion.
March 19, 2026

Vinge has advised Cinclus Pharma in connection with entering into financing agreement

Vinge has advised Cinclus Pharma Holding AB (publ), a late-stage clinical pharmaceutical company developing next-generation treatments for gastric acid-related diseases listed on Nasdaq Stockholm, in connection with a long-term structured credit agreement for a total of up to EUR 28 million divided into four tranches, of which two are convertibles.
March 16, 2026

Vinge advises Studentbostäder i Norden AB (publ) in connection with its issuance of bonds in an amount of SEK 500 million and its early redemption of outstanding bonds

Vinge has advised Studentbostäder i Norden AB (publ) in connection with its issuance of senior unsecured bonds in an amount of SEK 500 million (within a framework of SEK 750 million) and in parallel with the company's voluntary early redemption of previously issued bonds.
March 12, 2026